Rare Disease Treatments
Pharmaceutical and biotech companies developing orphan drugs and therapies for rare diseases affecting small patient populations
Symbols
LLYLilly(Eli) & CoMarket Cap: $921.5B
ABBVAbbvie IncMarket Cap: $410.7B
NOVNNovartis AGMarket Cap: $260.5B
NVONovo NordiskMarket Cap: $217.7B
AMGNAMGEN Inc.Market Cap: $181.3B
VRTXVertex Pharmaceuticals, Inc.Market Cap: $110.9B
KPTIKaryopharm Therapeutics IncMarket Cap: $96.8B
BRMBristol-Myers Squibb Co.Market Cap: $95B
BMYBristol-Myers Squibb Co.Market Cap: $95B
REGNRegeneron Pharmaceuticals, Inc.Market Cap: $72.9B
SNYSanofiMarket Cap: $65.9B
ALNYAlnylam Pharmaceuticals IncMarket Cap: $59.3B
ARGXArgen X SEMarket Cap: $55.2B
INSMInsmed IncMarket Cap: $41.2B
EDGGold Fields LtdMarket Cap: $36.5B
ZLABZai Lab LimitedMarket Cap: $31.8B
BIIBBiogen IncMarket Cap: $24.6B
TAKTakeda Pharmaceutical CoMarket Cap: $24.3B
INCYIncyte Corp.Market Cap: $20.4B
UTHRUnited Therapeutics CorpMarket Cap: $20.1B